Mucosal Microbiome in Human Gastric Intestinal Metaplasia and Duodenal Tissue.
NCT ID: NCT02428426
Last Updated: 2015-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2014-09-30
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gene Expression Profiling in Human Gastric Intestinal Metaplasia Mucosa and Duodenal Mucosa
NCT02846688
Association Between Confocal Laser Endomicroscopic (CLE) Features and Gastric Mucosal Microbiome
NCT02063932
Study of Gastric Motility in Eosinophilic Gastritis
NCT05229432
The Effact of Helicobacter Hylori Eradication on the Development of Gastric Mucosa Pathology
NCT04029441
Effect of Hp Infection on the Quality of Gastric Mucosa Preparation
NCT05527496
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
gastric intestinal metaplasia
patients were diagnosed gastric intestinal metaplasia
endomicroscopy, targeted biopsy and 16s rRNA gene sequencing
gastritis
patients were diagnosed non atrophic gastritis
endomicroscopy, targeted biopsy and 16s rRNA gene sequencing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
endomicroscopy, targeted biopsy and 16s rRNA gene sequencing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shandong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yanqing Li
Mucosal Microbiome in human gastric Intestinal Metaplasia and duodenal tissue.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
li yanqing, PhD,MD
Role: PRINCIPAL_INVESTIGATOR
Qilu Hospital, Shandong University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015SDU-QILU-G04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.